Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of hexarelin and GHRP-2 in humans

Journal of Endocrinological Investigation

Volumn 22, Issue 2, 1999, Pages 91-97

  Arvat, E ^a   Di Vito, L ^a   Lanfranco, F ^a   Broglio, F ^a   Giordano, R ^a   Benso, A ^a   Muccioli, G P ^a   Deghenghi, R ^b   Ghigo, E ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b Ardana   (France)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

ACTH; Cortisol; GH; GHRP 2; Hexarelin; Humans; PRL; Tyr Ala Hexarelin

Indexed keywords

CORTICOTROPIN; HEXARELIN; HYDROCORTISONE; PRALMORELIN; PROLACTIN; SYNTHETIC PEPTIDE;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; ENDOCRINE FUNCTION; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPOPHYSIS; HYPOTHALAMUS; INTRAVENOUS DRUG ADMINISTRATION; IODINATION; MALE; NORMAL HUMAN; PROLACTIN RELEASE; RANDOMIZED CONTROLLED TRIAL;

EID: 0033015381     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03350886     Document Type: Article

References (43)

1. Bowers C.Y., Veeraragavan K., Sethumadhavan K. Atypical growth hormone releasing peptides. In: Bercu B.B., Walker R.F. (Eds.), Growth hormone II, basic and clinical aspects. Springer-Verlag , New York, 1993, p. 203.
2. Deghenghi R., Boutignon F., Luoni M., Grilli R., Guidi M., Locatelli V. Small peptides as potent releasers of growth hormone. J. Pediatr. Endocrinol. Metab. 8: 311, 1995.
3. Ghigo E., Arvat E., Muccioli G., Camanni F. Growth hormone-releasing peptides. Eur. J. Endocrinol. 136: 445, 1997.
4. Korbonits M., Grossman A.B. Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release. Trends Endocrinol. Metab. 6: 43, 1995.
5. Smith R.G., Van der Ploeg L.X.T., Howard A.D., Feighner S.D., Cheng K., Mickey G.J., Wyvratt M.J., Fisher M.H., Nargund R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 18: 621, 1997.
6. Jacks T., Mickey G., Judith F., Taylor J., Chen H., Krupa D., Feeney W., Schoen W., Fisher M., Wyratt M., Smith R. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles. J. Endocrinol. 143: 399, 1994.
7. Thomas G.B., Fairhall K.M., Robinson I.C.A.F. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138: 1585, 1997.
8. Korbonits M., Trainer P.J., Besser G.M. The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin. Endocrinol. (Oxf.) 43: 365, 1995.
9. Ghigo E., Arvat E., Gianotti L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. J. Clin. Endocrinol. Metab. 78: 693, 1994.
10. Ghigo E., Arvat E., Ramunni J., Colao A., Gianotti L., Deghenghi R., Lombardi G., Camanni F. Adrenocorticotropin-and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 82: 2439, 1997.
11. Arvat E., Di Vito L., Maccagno B., Broglio F., Boghen M.F., Deghenghi R., Camanni F., Ghigo E. Effects of GHRP-2 and Hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol level in man. Comparison with the effects of GHRH, TRH, and hCRH. Peptides 18: 885, 1997.
12. Arvat E., Maccagno B., Ramunni J., Di Vito L., Broglio F., Deghenghi R., Camanni F., Ghigo E. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Neuroendocrinology 66: 432, 1997.
13. Ciccarelli E., Grottoli S., Razzore P., Gianotti L., Arvat E., Deghenghi R., Camanni F., Ghigo E. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinemia patients. Clin. Endocrinol. (Oxf.) 44: 67, 1996.
14. Arvat E., Ramunni J., Bellone J., Di Vito L., Baffoni C., Broglio F., Deghenghi R., Bartolotta E., Ghigo E. The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations. Eur. J. Endocrinol. 137: 635, 1997.
15. Arvat E., Maccagno B., Ramunni J., Broglio F., Lanfranco F., Giordano R., Benso A., Deghenghi R., Ghigo E. Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in young women. J. Endocrinol. Invest., 21: 673, 1998.
16. Muccioli G., Ghè C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F., Nilsson M.H.L., Deghenghi R., Ong H., Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 157: 99, 1998.
17. Codd E.E., Shu A.Y.L, Walker R.F. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology 28: 1139, 1989.
18. Pong S.S., Chaung L.Y.P., Dean D.C., Nargunt P.P., Patchett A.A., Smith R.G. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol. 10: 57, 1996.
19. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Cheung L.Y., Elbrecth A., Dashkevicz M., Heavehs R., Rigby M., Sirinatsinghji D.J.S., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974, 1996.
20. 125I] p-benzoyl-phenylalanine Hexarelin derivative. Endocrinology 139: 432, 1998.
21. Bowers C.Y., Sartor A.O., Reynolds G.A., Badger T.M. On the action of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128: 2027, 1991.
22. Popovic V., Damjanovic S., Micic D., Djurovic M., Dieguez C., Casanueva F.F. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J. Clin. Endocrinol. Metab. 80: 942, 1995.
23. Mickey G.J., Drisko J., Faidley T., Chang C., Anderson L., Nicolich S., McGuire L., Riches E., Kripe D., Feeney W., Friscino R., Cunnighan P., Frazier E., Chen H., Leroque P., Smith R.G. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J. Endocrinol. 148: 371, 1996.
24. Loche S., Cambiaso P., Merola B., Colao A., Faedda A., Imbimbo B.P., Deghenghi R., Lombardi G., Cappa M. The effect of Hexarelin on growth hormone (GH) secretion in patients with GH deficiency. J. Clin. Endocrinol. Metab. 80: 2692, 1995.
25. Mallo F., Alvarez C.V., Benitez L., Burguera B., Coya R., Casanueva F.F., Dieguez C. Regulation of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP6)-induced GH secretion in the rat. Neuroendocrinology 57: 247, 1993.
26. Goth M.I., Lyons C.E., Canny B.Y., Thorner M.O. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 130: 939, 1992.
27. Fairhall K.M., Mynett A., Robinson I.C.A.F. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J. Endocrinol. 144: 555, 1995.
28. Dickson S.L., Luckman S.M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH segretagogue, GH-releasing peptide-6. Endocrinology 138: 771, 1997.
29. Guillame V., Magnam E., Cataldi M., Dutour A., Sauze N., Renard M., Rezafindraibe H., Conte Devol B., Lenaertz V., Oliver C. Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135: 1073, 1994.
30. Conley L.K., Teik J.A., Deghenghi R., Imbimbo B.P., Giustina A., Locatelli V., Wehrenberg W.B. Mechanism of action of Hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat. Neuroendocrinology 61: 44, 1995.
31. Pandya N., DeMott-Friberg R., Bowers C.Y., Barkan A.L., Jaffe C.A. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J. Clin. Endocrinol. Metab. 83: 1186, 1998.
32. Arvat E., Gianotti L., Ramunni J., Di Vito L., Deghenghi R., Camanni F., Ghigo E. Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man. J. Endocrinol. Invest. 19: 25, 1996.
33. Adams E.F., Petersen B., Ting L., Buchfelder M., Fahlbusch R. The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors. Biochem. Biophys. Res. Commun. 208: 555, 1995.
34. Grottoli S., Razzore P., Arvat E., Oleandri S.E., Rossetto R., Ciccarelli E., Camanni F., Ghigo E. Reduction of the somatotrope responsiveness to GHRH and hexarelin but not to arginine plus GHRH in hyperprolactinemic patients. J. Endocrinol. Invest. 20: 597, 1997.
35. Arvat E., Maccagno B., Ramunni J., Gianotti L., Di Vito L., Deghenghi R., Camanni F., Ghigo E. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or Hexarelin, a synthetic hexapeptide, in man. J. Endocrinol. Invest. 20: 122, 1997.
36. Shimon I., Van X., Melmed S. Human fetal pituitary expresses functional growth hormone-releasing peptide receptors. J. Clin. Endocrinol. Metab. 83: 174, 1998.
37. Elias K.A., Ingle G.S., Burnier J.P., Hammonds R.G., McDowell R.S., Rawson T.E., Somers T.C., Stanley M.S., Cronin M.J. In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 136: 5694, 1995.
38. Smith R.G., Cheng K., Pong S.S., Hickey G., Jacks T., Butler B., Chan W.W.S., Chaung L.Y.P., Judith F., Taylor J., Schoern W.R., Wyvratt M.J., Fisher M.H. A non-peptidyl growth hormone secretagogue. Science 260: 1640, 1993.
39. Bowers C.Y. GH releasing peptides; structure and kinetics. J. Pediatr. Endocrinol. 6: 21, 1993.
40. Sethumadhavan K., Veeraragavan K., Bowers C.Y. Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes. Biochem. Biophys. Res. Commun. 178: 31, 1991.
41. Veeraragavan K., Sethumadhavan K., Bowers C.Y. Growth hormone-releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes. Life Sci. 50: 1149, 1992.
42. De Keyzer Y., Lenne F., Bertagna X. Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors. Eur. J. Endocrinol. 137: 715, 1997.
43. Jansson J.O., Svensson J., Bengtsson B.A., Frohman L.A., Ahlmant H., Wangberg B., Nilsson O., Nilsson M. Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6. Clin. Endocrinol. (Oxf.) 48: 243, 1998.